Prothena Corp (PRTA)
59.97
+1.83 +3.15%
NASDAQ
Sep 30, 20:00
Delayed 2m
USD
View All Key Stats
PRTA Key Stats
| Income Statement | |
| Revenue (TTM) | 1.334M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -3.49 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -115.10M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -12.15K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 2.063B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 1477.33 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 4.787 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.00 |
| Free Cash Flow (Quarterly) | -28.23M |
| Return on Equity (TTM) | -28.34% |
View All PRTA News
PRTA News
-
WireHeadlineTime (ET)
-
Yahoo09/30 16:54
-
Globe Newswire09/30 14:45
-
MT Newswires09/30 07:42
-
Yahoo09/29 16:08
-
Globe Newswire09/29 16:05
-
MT Newswires09/27 14:51
-
SA Breaking News09/26 17:01
-
Yahoo09/26 16:13
-
Globe Newswire09/26 16:05
-
MT Newswires09/23 07:09
View All Events
PRTA Events
| Date | Type | Description |
|---|---|---|
| 02/18/2016 16:30 EDT | Misc | Prothena Corp PLC Fourth Quarter Earnings Conference Call in 2015 |
| 02/18/2016 | Earnings | Prothena Corp PLC Fourth Quarter Earnings in 2015 Release |
PRTA Fundamentals
Income Statement View Statement
PRTA Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.prothena.com
- Investor Relations URL: http://ir.prothena.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: February 18, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Prothena Corp PLC is a biotechnology company. It discovers and develops novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.
PRTA Comparables
EditPRTA Excel Add-In Codes
- Name: =YCI("PRTA","name")
- Description: =YCI("PRTA","description")
- Sector: =YCI("PRTA","sector")
- Industry: =YCI("PRTA","industry")
- Est. Current Fiscal Year End: =YCI("PRTA","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other PRTA Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PRTA Tweets Stocktwits
Advertisement